The efficiency of Neuromidin in the comprehensive treatment of diabetic distal symmetric polyneuropathy
Journal Title: Міжнародний ендокринологічний журнал - Year 2019, Vol 15, Issue 3
Abstract
Background. The purpose of the study is to establish the efficiency and safety of the use of ipidacrine (Neuromidin) in patients with type 2 diabetes mellitus complicated by distal symmetric polyneuropathy. Materials and methods. One hundred ten patients with distal symmetric polyneuropathy were examined. Selected patients were divided into 2 groups: group I (n = 24) — persons receiving basic treatment; group II (n = 50) — patients who received Neuromidin, in the form of intramuscular injections of 5 mg 2 times a day for 10 days, then orally 20 mg 3 times a day for 20 days. All patients underwent neurological examination using Neuropathy Symptom Score, Neuropathy Disability Score, electroneuromyographic (ENMG) testing of the peripheral nerves of the lower extremities. In order to establish the peculiarities of cognitive functions, Mini-Mental State Examination was used. Also, the rates of anxiety and depression in the dynamics of treatment were assessed. Results. In the group of people who received Neuromidin on the background of basic treatment, there was a significant improvement in the subjective and objective symptoms. The manifestations of axonopathy and myelinopathy according to the results of ENMG testing of peripheral nerves were believed to decrease in the group of patients taking Neuromidin against the background of basic treatment. Also, a statistically significant improvement of cognitive functions, reduction of anxiety and depression manifestations was established with the administration of Neuromidin. Conclusions. The application of Neuromidin on the background of basic therapy in patients with distal symmetric polyneuropathy improves the processes of regeneration and reinnervation of the peripheral nerves of the lower extremities and improves motor fibers conduction according to the ENMG parameters, has a positive effect on the clinical course of the disease, as well as improves cognitive function, reduces manifestations of anxiety and depression.
Authors and Affiliations
N. V. Pashkovska, V. M. Pashkovsky, I. А. Zoriy
Keywords
Related Articles
- EP ID EP605834
- DOI 10.22141/2224-0721.15.3.2019.172109
- Views 45
- Downloads 0
Laboratory Diagnosis of Some Components of Metabolic Syndrome
Metabolic syndrome is a complex of interrelated risk factors for cardiovascular diseases and diabetes mellitus. The prevalence of metabolic syndrome grows progressively all over the world due to the increased number of p...
Legal Work of the Doctor at the Stage of Primary Health Care
The article deals with the main problems of medical care providing in primary health care, as well as the settlement of legal relations arising in the work of the doctor, and the need for systematization of legal acts wh...
Chornobyl Accident and Iodine Deficiency as Risk Factors of Thyroid Pathology in Population of the Affected Regions of Ukraine
The result of the Chornobyl nuclear power plant accident was the negative effect of radiation on the health of population of large areas of Ukraine and surrounding countries, the impact of this action will be shown over...
Vitamin D Content and the State of Bone Metabolism in Patients with Syndrome of Hyperthyroidism (Review of Literature)
The literature review presents data of researches on the content of vitamin D and the state of bone metabolism in patients with syndrome of hyperthyroidism. Overt hyperthyroidism is associated with accelerated bone remod...
Insulin Toujeo® — a Novel Basal Long-Acting Insulin Formulation Part 2. Clinical Efficacy and Safety
This review, consisting of two parts, considers a new formulation of insulin glargine (rDNA origin) in the form of injections 300 U/ml (Gla-300, Toujeo®). Gla-300 is a next generation basal insulin with a novel formulati...